Hims & Hers Health, Inc. (HIMS) Tops Q4 EPS by 1c, Guidance Beats

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Hims & Hers Health, Inc. (HIMS) Tops Q4 EPS by 1c, Guidance Beats

Hims & Hers Health, Inc. Reports Record Fourth Quarter and Full Year 2022 Financial Results

February 27, 2023 4:15 PM EST

Full year 2022 revenue of $526.9 million, up 94% year-over-year

Q4 2022 record revenue of $167.2 million, up 97% year-over-year

Q4 2022 net loss of $10.9 million and achieves Adjusted EBITDA profitability of $3.9 million

Eclipses one million subscribers at year end, up 88% year-over-year

Provides Q1 and full year 2023 guidance, with full year 2023 revenue in the range of $735 million to $755 million and Adjusted EBITDA in the range of $20 million to $30 million

Introduces 2025 targets of at least $1.2 billion in revenue and $100 million in... More